Kell Cannon brings more than 20 years of U.S. and global lifecycle and pharmaceutical marketing expertise to 3D’s clients. Kell uses his analytical and organizational skills to help clients identify the strengths and weaknesses in their data and define their competitive differentiation. He has developed rigorous processes to help clients analyze and prepare their regulatory submissions and FDA advisory committee presentations. This assistance enables companies to win approval, expedite product access, and achieve competitive reimbursement. Kell has held leadership positions at Roche, Novartis, Ciba, and Merck in clinical trial strategy, label negotiations, brand positioning, and advocacy development. Kell has an MBA and a BS in Microbiology.